BioWorld1 个月
Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...